CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on creating and providing treatments for liver and various other chronic conditions. Its leading investigational drug is seladelpar (MBX-8025), a selective agonist for the peroxisome proliferator activated receptor delta, which isโฆ